Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2026-01-10 @ 5:56 AM
Study NCT ID:
NCT06738303
Status:
RECRUITING
Last Update Posted:
2025-08-27
First Post:
2024-12-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
Sponsor:
Case Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE13824
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None